Table 6.
Model 1 | Weight Loss >5% | Weight Loss <5% | p | |
SGA | C | 15 (60%) | 10 (40%) | 0.407 |
miRNA-130a | Low expression | 27 (73%) | 10 (27%) | |
Model 2 | High TNF-α + Weight Loss >5% | Low TNF-α + Weight Loss <5% | p | |
SGA | C | 13 (86.7%) | 2 (13.3%) | 0.550 |
miRNA-130a | Low expression | 22 (95.7%) | 1 (4.3%) | |
Model 3 | Weight Loss >10% | Weight Loss <10% | p | |
SGA | C | 8 (33.3%) | 16 (66.7%) | 0.049 |
miRNA-130a | Low expression | 22 (59.5%) | 15 (40.5%) | |
Model 4 | High TNF-α + Weight Loss >10% | Low TNF-α + Weight Loss <10% | p | |
SGA | C | 9 (69.2%) | 4 (30.8%) | 0.387 |
miRNA-130a | Low expression | 18 (85.7%) | 3 (14.3%) |